Aligned Genetics, Inc.

KOSDAQ:A238120 Rapporto sulle azioni

Cap. di mercato: ₩40.8b

Aligned Genetics Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Yeon-Cheol Jung

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOno data
Proprietà del CEO20.5%
Durata media del managementNessun dato
Durata media del Consiglio di amministrazioneNessun dato

Aggiornamenti recenti sulla gestione

Recent updates

Aligned Genetics, Inc.'s (KOSDAQ:238120) Business Is Yet to Catch Up With Its Share Price

Aug 12
Aligned Genetics, Inc.'s (KOSDAQ:238120) Business Is Yet to Catch Up With Its Share Price

If You Like EPS Growth Then Check Out Aligned Genetics (KOSDAQ:238120) Before It's Too Late

Apr 06
If You Like EPS Growth Then Check Out Aligned Genetics (KOSDAQ:238120) Before It's Too Late

Update: Aligned Genetics (KOSDAQ:238120) Stock Gained 29% In The Last Three Years

Feb 11
Update: Aligned Genetics (KOSDAQ:238120) Stock Gained 29% In The Last Three Years

AMMINISTRATORE DELEGATO

Yeon-Cheol Jung (54 yo)

no data

Mandato

Mr. Yeon-Cheol Jung serves as the Chief Executive Officer at Aligned Genetics, Inc. (formerly known as Logos Biosystems, Inc.). Mr. Jung is an Insider at Aligned Genetics, Inc. (formerly known as Logos Bio...